Processing Search... May Take A Few Moments

Join | Login





  • Home
    • Articles Hub
  • C | Community
    • Connect
      • Information about Membership
        • Become a Member
      • Stories
        • UCD Community
        • PKU Community
        • HCU Community Stories
        • MSUD Community Stories
      • Networking Groups
    • Events
      • Building Bridges Learning Network
      • Camp MagniPHEque - Sept 2026
      • Past Events
        • Avery's Ride for PKU - 2014
  • A | Advocacy
    • Rare Awareness Radio Podcasts
    • Advocacy at Home
    • Advocacy Toolkit
    • Access
      • Advocacy - Sephience
      • Getting access to Pegzilarginase
  • R | Research
    • Registries
    • Research Studies
    • Publications
    • Innovation & Therapies
      • Digital Tools - Apps
        • Sources and Methodology
      • Therapies and Treatments
    • Researchers and Partners Hub
  • E | Education
    • Understanding the Disorder
      • Understanding PKU
      • Understanding HCU
      • Understanding MSUD
      • Understanding UCDs
        • Think Ammonia
    • Nourish Landing
      • Low Protein Basics
      • Grocery Shopping
      • Medical Nutrition
      • Recipes and Meal Inspiration
      • Clinic & Clinical Care
    • Flourish Landing
      • Physical & Energy Balance
      • Sustainable Living
      • Social & Everyday Life
      • Mental Wellbeing
    • Life Stages and Milestones
      • New Diagnosis
      • Infancy and Early Childhood
      • Children and Youth
      • Teens
      • Adults
      • Aging with a Metabolic Disorder
      • Women's Health
      • Caregiver
  • S | Sustain
    • Community Supports
      • Travel Scholarships
      • Disability Tax Credit - Basic Information
    • CanPKU+ Sustainability
      • Donate
      • Fundraising
        • National Spare for Rare
        • HCU - Race for Research
        • Past Fundraising
      • Partnerships with Clinics
      • Partnership with Sponsors
      • Our Valuable Sponsors
      • Partnerships In Kind
      • Ways to make payments
  • .
    • Un câlin pour toi
    • Envoyer un câlin
    • Call for Abstracts/Presenters
    • Sending Hugs
    • Sending You Hugs
    • Sending Big Hugs
    • Waiver - Teen Lounge/ détente des adolescent
    • Waiver - Childcare-Programme supervisér
    • Waiver - photo, vidéo, audio
    • Waiver - Shuttle/Navette


Want to come right back here? Bookmark: www.canpku.org/education/treatments
Treatment & Care
Treatment is personal. You do not have to navigate it alone.
People living with PKU, HCU, MSUD and UCDs may share some parts of metabolic care, while other treatments are very specific to the condition, subtype or individual.

This page gives you the big picture and helps you understand the different tools that may be part of care.
Important: Treatment plans are individualized. Diagnosis, subtype, age, laboratory results, response to treatment, health history, pregnancy or life stage, and other factors can all affect care. Always follow the recommendations of your metabolic clinic.
What Do Our Metabolic Conditions Have in Common?
The details are different, but treatment for many inherited metabolic disorders is built from several of the same kinds of care.
Medical Nutrition
Diet may be used to control specific amino acids or protein while still providing enough energy and nutrients for growth, development and health. Some people also use metabolic formula, protein substitutes, specialty low-protein foods or supplements.
Monitoring
Bloodwork and other follow-up help the metabolic team understand how treatment is working and when something needs to change. Growth, nutrition, development and overall health may also be followed over time.
Medications & Supplements
Some conditions have medications or vitamin/cofactor therapies that can improve metabolic control. Others rely more heavily on nutrition or use medicines only in certain subtypes or situations.
Lifelong Care
Treatment needs can change through childhood, adolescence, adulthood, pregnancy and aging. Transition between pediatric and adult care is part of long-term metabolic management.
Planning for Illness
Illness, fasting, vomiting, surgery or other stress may affect metabolic control. The degree of urgency varies significantly between conditions, but families and adults should know when to contact their clinic and whether they need a sick-day or emergency plan.
Access Matters
Formula, medical foods, supplements and medications may follow different funding pathways across Canada. Your clinic and pharmacy can help determine which access route applies where you live.
What Is Different for Each Disorder?
Select your condition for a plain-language overview of the treatment approaches you may hear about.
PKU Treatments & Therapies
PKU treatment focuses on keeping phenylalanine (Phe) in a safe range while supporting nutrition, health and development. A person's treatment may include diet, medical formula or protein substitute, medication, or a combination of approaches.
Medical nutrition
PKU dietary therapy limits phenylalanine while providing adequate protein, calories and nutrients. This may include Phe-free or low-Phe metabolic formula, protein substitutes, specialty low-protein foods and clinic-directed supplements.
Medications used in PKU care
Kuvan / sapropterin and authorized generics
Sapropterin is used in people with BH4-responsive PKU. In responders it may lower blood Phe and may increase dietary Phe tolerance. Responsiveness is assessed with the metabolic clinic.
Palynziq (pegvaliase)
Pegvaliase is an enzyme-substitution therapy used in eligible people with PKU who have inadequate Phe control despite dietary management. Treatment involves staged dosing and close medical monitoring.
Sephience (sepiapterin)
Sepiapterin is used for sepiapterin-responsive PKU together with a Phe-restricted diet. Your clinic determines responsiveness, appropriate use and monitoring.
Regular blood Phe monitoring remains an important part of PKU care. Treatment and dietary tolerance can vary considerably between individuals.
Explore Medical Nutrition
HCU Treatments & Therapies
About this section: This information focuses primarily on classical HCU caused by CBS deficiency. Other disorders that cause high homocysteine, including cobalamin and remethylation disorders, may require a different treatment approach.
Classical HCU treatment focuses on lowering homocysteine, maintaining appropriate methionine levels, supporting healthy growth and development, and reducing complications such as blood clots.
Treatment may include
  • A methionine-restricted diet and metabolic formula, particularly for people who are not fully B6 responsive
  • Pyridoxine (vitamin B6) in people whose HCU responds to B6
  • Folate and vitamin B12 support when indicated
  • Betaine, including betaine anhydrous, to help lower homocysteine
  • Ongoing monitoring of homocysteine, methionine, nutrition and other health concerns
Clot risk matters. Thromboembolism is an important complication of classical HCU. Surgery, immobility, pregnancy/postpartum and previous clotting history may require additional planning with the healthcare team.
Other homocysteine disorders
Cobalamin-related and remethylation disorders are not the same as classical CBS-deficiency HCU. Treatments may include hydroxocobalamin, betaine, folate-related therapies and other clinic-directed approaches depending on the exact diagnosis.
HCU Emergency Preparedness Toolkit
MSUD Treatments & Therapies
MSUD treatment focuses on controlling the branched-chain amino acids leucine, isoleucine and valine, supporting growth and nutrition, and preventing metabolic crises.
Medical nutrition is foundational.
Many people with MSUD follow a carefully controlled low-BCAA diet together with BCAA-free metabolic formula. Individual amino-acid intake is adjusted using blood results, growth, age and clinical stability.
Other treatment considerations
  • A small subset of people may have thiamine-responsive MSUD and may use clinic-directed high-dose vitamin B1
  • Regular plasma amino-acid monitoring, particularly leucine, guides ongoing care
  • Illness, fasting, injury, surgery or poor intake can cause rapid metabolic instability
Metabolic crises can be urgent. Severe elevations in leucine may require hospital treatment. Emergency care can include IV calories, temporary changes to protein intake and formula, and in severe situations dialysis or hemofiltration.
Liver transplantation may be considered for some people with MSUD and can greatly reduce the risk of metabolic crises. Transplantation is a major medical decision and requires lifelong follow-up and immunosuppression.
Urea Cycle Disorder Treatments & Therapies
UCD treatment focuses on preventing the buildup of ammonia, maintaining safe protein intake, supporting nutrition and responding rapidly when metabolic stability changes.
Common parts of UCD care
  • Protein-controlled nutrition
  • Specialized formula or calorie support when needed
  • Regular ammonia and biochemical monitoring
  • Nitrogen-scavenger medications in many UCDs
  • Arginine or citrulline supplementation in some subtypes
  • Emergency planning for hyperammonemia
Medications families may hear about
Ravicti (glycerol phenylbutyrate) and Pheburane (sodium phenylbutyrate) are nitrogen-scavenger therapies used in certain UCDs to support long-term ammonia control.
Carbaglu (carglumic acid) is a targeted therapy particularly associated with NAGS deficiency.
How treatment differs between UCD subtypes

NAGS deficiency: carglumic acid is an important targeted therapy.

CPS1 and OTC deficiency: treatment often includes protein management, nitrogen-scavenger therapy and citrulline and/or arginine, depending on the individual.

ASS1 deficiency (citrullinemia type I) and ASL deficiency: treatment may include protein management, scavenger therapy when needed and arginine supplementation.

ARG1 deficiency: management places additional emphasis on neurological and functional health. Treatment patterns can differ from UCDs in which recurrent hyperammonemia is the dominant concern.

Hyperammonemia is a medical emergency. Rapidly rising ammonia can affect the brain. Hospital care may include IV calories, temporary protein restriction, ammonia-scavenger therapy, arginine in selected protocols and dialysis when ammonia is dangerously high.
Liver transplantation may be considered in selected UCDs and can substantially reduce the risk of recurrent hyperammonemia, although it requires lifelong medical follow-up.
Sick-Day and Emergency Planning
The urgency of illness is not the same across all four disorders.

MSUD and many UCDs can involve rapid metabolic decompensation and may require urgent hospital care. Classical HCU has different emergency concerns, including blood-clot risk and planning around surgery, illness or immobility. PKU generally does not carry the same acute metabolic-crisis risk, but illness, poor intake and hydration can still require guidance from the metabolic clinic.

Ask your clinic whether you should have a sick-day plan, emergency letter or hospital protocol and keep it somewhere easy to access.
Access to Treatment in Canada
A treatment being medically appropriate does not always mean it follows the same access pathway everywhere in Canada.
Depending on the treatment and where you live, access may involve:
  • Provincial or territorial drug plans
  • Exceptional or special authorization processes
  • Metabolic formula or medical-food programs
  • Hospital or clinic-based supply
  • Private insurance
  • Non-Insured Health Benefits for eligible First Nations and Inuit clients
  • Case-by-case or other special access routes
Your metabolic clinic, pharmacy and insurer can help determine the current pathway for a specific therapy. Public coverage and product status can change, so CanPKU+ does not maintain a province-by-province guarantee of reimbursement on this page.
Health Canada Drug Product Database Our Work on Equitable Access
What if a therapy is not routinely available in Canada?
In certain circumstances, a physician may request access to a drug that is not marketed in Canada through Health Canada's Special Access Program (SAP). SAP requests are made by healthcare professionals for individual patients and are considered case by case.
Learn about Health Canada's Special Access Program
What About Treatments Still Being Studied?
New therapies are continually being researched for metabolic disorders. Because clinical-trial status and treatment pipelines can change quickly, investigational therapies are not maintained on this evergreen treatment page.

Visit Research & Innovation for current studies, research articles and emerging treatment developments.
Research Studies & Participation Research Articles & Updates
More Support for Day-to-Day Care
Nourish: Food & Nutrition Registries Access & Advocacy
Medical disclaimer: Information on this page is for general educational purposes and does not constitute medical advice. Treatments, targets, emergency plans and monitoring vary by diagnosis and individual.

Always work with your metabolic specialist and registered dietitian or other members of your healthcare team for individualized care.
Back to Top


Coming to Canada

Posted January 27, 2025 ♦

More...

   

   
Newer posts »
« Older posts
  
© Community Enterprise
lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec sagittis urna vel mauris interdum consequat




Back to top

© 2025 CanPKU | Privacy | Terms | CanPKU+ thanks Matty over at buzzdigital.ca  for covering the cost of hosting our websites.